PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 5, 2026Signal Transduction and Targeted Therapy0 citationsOpen Access

Inducible CD147 up-regulation boosts extended SARS-CoV-2 infection triggering severe COVID-19 independent of ACE2

View Full Paper
KWKe WangPLPeng LinRCRuo Chen

Key Points

  • This research investigates the role of CD147 in enhancing SARS-CoV-2 infection and its contribution to severe COVID-19 cases.
  • Analyzed lung tissues of virus-infected rhesus macaques
  • Examined CD147 and ACE2 gene expression levels
  • Studied the immune response changes, including cell death in CD4 + T cells and B cells
  • Administered Meplazumab to evaluate effects on virus entry and immune balance
  • Conducted cryo-EM analysis to explore CD147-spike interaction
  • SARS-CoV-2 infection leads to significant CD147 up-regulation and down-regulation of ACE2 in lung tissues
  • Enhanced expression and nuclear translocation of transcriptional factor aryl hydrocarbon receptor
  • Meplazumab reduces virus entry and cytokine levels, restoring immune balance
  • Cryo-EM structure reveals distinct residues in CD147-spike interaction affected by Meplazumab

Abstract

Abstract The high mortality caused by severe COVID-19 poses great challenges to the public health. However, the underlying pathogenesis of severe cases remains unclear. Here, we find that SARS-CoV-2 infection boosts CD147 inducible up-regulation in the lung tissues of virus-infected rhesus macaques coupled with down-regulated membrane-bound ACE2, which conduces to extended virus infection and severe pathological lesions. Specifically, SARS-CoV-2 infection enhances the expression of transcriptional factor aryl hydrocarbon receptor and facilitates its nucleus translocation, which causes CD147 gene transcription and its up-regulation in protein level, thereby leading to virus susceptibility of the hosts and extended virus infection. Meanwhile, SARS-CoV-2 infection triggers immune imbalance of lung tissues by promoting cell death of CD4 + T cells and B cells and mediating abnormal cell-cell communications, especially for M2 macrophages. Meplazumab, a humanized anti-CD147 antibody, effectively inhibits virus entry and cytokine level, and restores immune balance in the lung tissues of virus-infected rhesus macaque model. Importantly, we further present the cryo-EM structure of CD147-spike complex, and identify five pairs of functional residues for their interaction, which could be interrupted by Meplazumab via steric hindrance effect. Our findings provide direct evidence for CD147-SARS-CoV-2 spike interaction and uncover the pathogenesis of severe COVID-19 caused by CD147-mediated extended virus infection.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/6984346ff1d9ada3c1fb2979https://doi.org/10.1038/s41392-025-02551-x
Ask AI
Helpful
Bookmark
Share
View Full Paper